Merck KGaA Selects Veeva Vault CRM for Global Use
Merck KGaA, Darmstadt, Germany, has chosen Veeva Vault CRM for its global operations to support data connectivity and consistent processes across its healthcare business.
May 27, 2026
Life Sciences
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Subtle Medical Receives FDA Clearance for SubtleHD PET Imaging Software
Subtle Medical has received FDA clearance for SubtleHD PET, its AI-based PET image enhancement software designed to improve image quality and accelerate PET imaging workflows across PET/CT and PET/MR systems.
May 27, 2026
Chinese Study Tests AI Assisted Ultrasound for Detecting Carotid Artery Plaque
Researchers in Shanghai found that general practitioners could identify carotid artery plaque in high-risk patients using AI assisted portable ultrasound, though performance varied among practitioners.
May 27, 2026
L.E.K. Consulting Survey Shows Growing Financial Divide Among U.S. Health Systems
A new survey by L.E.K. Consulting finds that U.S. health systems are increasingly split between financially strong and struggling organizations, with policy uncertainty, access challenges, and selective AI investment shaping future strategies.
May 27, 2026
Ember LifeSciences Expands Series A to $27 Million with Amgen Ventures and TDF Ventures
Ember LifeSciences has added new strategic investments from Amgen Ventures and TDF Ventures, bringing its Series A funding total to $27 million. The company also announced the commercial launch of the Ember Cube 2, a reusable cold chain shipping solution with real-time monitoring and cloud tracking.
May 27, 2026
Debut and Natura Partner on AI Discovered Skin Longevity Ingredient for Latin America
Debut and Natura have announced a partnership to commercialize an AI discovered skin longevity ingredient complex, combining Debut’s biotechnology platform with Natura’s Amazonian bioactives expertise. Products could launch as early as 2027 following clinical validation.
May 27, 2026
Brain Navi Introduces NaoTrac Surgical Robot for Precision Neurosurgery
Brain Navi Biotechnology has introduced NaoTrac, a neurosurgical navigation robot that uses machine vision and 3D positioning to improve precision and reduce operation time in brain surgery.
May 26, 2026
Neurophet and VHIR Begin Joint Study on AI Imaging for Multiple Sclerosis
Neurophet has announced a collaboration with Spain’s Vall d'Hebron Institut de Recerca to advance AI algorithms for detecting multiple sclerosis lesions using MRI data. The study will use large datasets to validate Neurophet AQUA MS, which received FDA clearance in 2024.
May 26, 2026
Insilico Medicine and Human Longevity Partner on AI Foundation Model for Longevity Science
Insilico Medicine and Human Longevity have announced a collaboration to create a large-scale AI foundation model focused on longevity science, combining advanced multimodal modeling with extensive clinical and genomic datasets.
May 26, 2026
Deerborne Group to Attend ASCO 2026 and Highlight AI Platform COMPASS 360
The Deerborne Group announced that its senior leadership will attend the American Society of Clinical Oncology 2026 Annual Meeting in Chicago, where the firm will highlight its AI-enabled COMPASS 360 platform for diagnostics strategy and decision-making.
May 26, 2026
Parkinson's Foundation Identifies 2,000 Participants for Neuron23 Trial Through PD Trial Navigator
The Parkinson's Foundation has identified over 2,000 potential participants for Neuron23's NEULARK clinical trial using its new PD Trial Navigator program, which connects genetically eligible individuals with Parkinson's disease to relevant studies.
May 26, 2026
Octagos Launches Ask Atlas for Cardiac Device Clinics
Octagos has introduced Ask Atlas, an AI tool that enables cardiac device clinics to query their clinical, operational, and billing data using natural language. The platform, built on Atlas AI, was previewed at the Heart Rhythm Society meeting in April 2026.
May 26, 2026
bitBiome Closes Oversubscribed Seed Extension Round
Tokyo and Palo Alto-based biotechnology company bitBiome has closed an oversubscribed seed extension round, bringing its total equity and non-dilutive funding to over 45 million USD. The company plans to expand its microbial enzyme discovery and engineering platforms and strengthen its global partnerships.
May 26, 2026
Prezent Vivo and Nested Knowledge Partner on AI Competitive Intelligence for Life Sciences
Prezent Vivo and Nested Knowledge have formed a strategic partnership to deliver AI powered competitive intelligence to life sciences teams, combining communication and evidence synthesis technologies to accelerate congress preparation and ongoing insights.
May 26, 2026
Tata Elxsi Unveils ViTel Material Intelligence Platform for Medical Device Manufacturers
Tata Elxsi has introduced ViTel, a material intelligence platform co-developed with Viridium AI to help medical device manufacturers manage sourcing, compliance, and engineering decisions through AI-powered data integration.
May 26, 2026
b.well Connected Health and myTomorrows Partner to Improve Clinical Trial Access
b.well Connected Health and myTomorrows have announced a partnership to streamline clinical trial access by combining unified health data with AI-based trial matching technology.
May 26, 2026
NeuroXT and BIDMC Expand Research Collaboration on AI-Based Alzheimer's Treatment
NeuroXT and Beth Israel Deaconess Medical Center have entered a new phase of their collaboration to advance precision treatment for Alzheimer's disease using AI-based neuroimaging biomarkers.
May 26, 2026
HkeyBio Expands Wet Lab Validation Capabilities for AI Drug Discovery
HkeyBio has announced an expansion of its preclinical services for autoimmune and allergic diseases, adding new wet lab validation platforms and CRO service upgrades to meet growing demand from AI-driven drug discovery companies.
May 26, 2026
ABILITY Neurotech Receives Approval for Chronic Brain Implant Study in ALS Patients
ABILITY Neurotech has received approval from Dutch regulators to begin a chronic implantation clinical trial for its fully implantable brain-computer interface in ALS patients. The study will be conducted at UMC Utrecht under the INTRECOM consortium.
May 26, 2026
Verified Market Research Projects Glucose Tracking App Market to Reach 12 Billion Dollars by 2033
Verified Market Research projects the global glucose tracking app market to grow from 5 billion dollars in 2025 to 12 billion dollars by 2033, driven by AI-based decision support and connected diabetes management tools.
May 26, 2026
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
